1. A genetic enrichment strategy for delay of onset of Alzheimer's disease clinical trials: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation. (7th December 2020) Authors: Lutz, Michael W.; Burns, Daniel K.; Alexander, Robert; Culp, Meredith; Yarnall, David; Haneline, Stephen; Chiang, Carl; Lai, Eric; Metz, Craig; Sundseth, Scott; Guennel, Tobi; Marshall, Scott; Andruss, Bernard F.; Latham, Gary J.; Hall, Bradley; Statt, Sarah N.; Swanson, Tom; Ratti, Emiliangelo; ... Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 5 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1‐050: ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY‐OF‐ONSET PHASE 3 CLINICAL TRIAL. (1st July 2006) Authors: Chiang, Carl; Alexander, Robert; Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Romero, Heather; Hayden, Kathleen M.; Keefe, Richard SE.; Atkins, Alexandra S.; Harrigan, Patrick; O'Neil, Janet; Culp, Meredith; Walter, Ryan; Wu, Jingtao; Randle, LaDonna; Haneline, Stephen; Yarbrough, Deborah; Met... Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 5 Page Start: P286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY. (1st July 2014) Authors: Budur, Kumar; Welsh‐Bohmer, Kathleen; Burns, Daniel; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Cyganowski, Marcia; Crenshaw, Donna G.; Lutz, Michael W.; Metz, Craig; Saunders, Ann; Yarbrough, Deborah; Yarnall, David; Lai, Eric; Brannan, Stephen; Roses, Allen D. Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 22 Page Start: P809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P4‐383: Characterization of the Screened Population for the Tommorrow Study: a Pharmacogenetics‐Supported Clinical Trial to Delay the Onset of Mild Cognitive Impairment Due to Alzheimer'S Disease. (1st July 2016) Authors: Martenyi, Ferenc; Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Harrigan, Patrick; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Culp, Meredith; Lutz, Michael W.; Lai, Eric; Saunders, Ann M.; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Burns, Daniel K.; Roses, Allen D. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2014)Part 24 Page Start: P1184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P4–065: A pharmacogenetics‐supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease. (1st July 2013) Authors: Roses, Allen; Welsh‐Bohmer, Kathleen; Burns, Daniel; Chiang, Carl; Crenshaw, Donna G.; Lutz, Michael W.; Metz, Craig; Saunders, Ann M.; Yarbrough, Deborah; Ogrinc, Francis; Talbott, Sheila; Brannan, Stephen; Malholtra, Manoj Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 18 Page Start: P727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial. Issue 1 (1st January 2019) Authors: Burns, Daniel K.; Chiang, Carl; Welsh‐Bohmer, Kathleen A.; Brannan, Stephen K.; Culp, Meredith; O'Neil, Janet; Runyan, Grant; Harrigan, Patrick; Plassman, Brenda L.; Lutz, Michael; Lai, Eric; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Ponduru, Sridevi; Sundseth, Scott; Sa... Journal: Alzheimer's & dementia Issue: Volume 5:Issue 1(2019) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗